Breaking News

MCM, LabCorp Expand Access to Global Central Lab Services

To extend service offerings to clients in Japan and globally

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Mitsubishi Chemical Medience Corp. (MCM) has signed a Master Service Agreement with the clinical trials division of Laboratory Corporation of America that allows LabCorp Clinical Trials and MCM to extend their service offerings to clients in Japan and around the world, respectfully.   “Pharmaceutical sponsors everywhere continue to look to new markets and technologies for drug development opportunities, and our clients are no different,” said Mr. Shinichi Yoshihara, president and chi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters